Cover Image
市場調查報告書

藥劑溶出性血管支架的全球市場:2016∼2020年

Global Drug-Eluting Stent Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 294940
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
藥劑溶出性血管支架的全球市場:2016∼2020年 Global Drug-Eluting Stent Market 2016-2020
出版日期: 2016年02月24日 內容資訊: 英文 56 Pages
簡介

藥劑溶出性血管支架,作為治療由於高血壓和抽煙,高膽固醇飲食而發病的動脈粥狀硬化病的患者。全球藥劑溶出性血管支架市場,預計2016∼2020年以年複合成長率3.45%擴大。

本報告提供全球藥劑溶出性血管支架市場現狀與今後的成長預測,各地區趨勢,以及市場趨勢與課題,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 藥劑溶出性血管支架:概要

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 藥劑溶出性血管支架所採用的藥物

第8章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 主要國家

  • 美國
  • 中國
  • 德國
  • 日本

第10章 推動市場的要素

第11章 促進要素的影響

第12章 市場課題

第13章 促進要素及課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • 主要供應商分析
  • Abbott Laboratories
  • Biosensors International
  • Boston Scientific
  • Medtronic
  • Terumo Corporation (Japan)
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR8832

About Drug-Eluting Stent

Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body's natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.

Technavio's analysts forecast the global drug-eluting stent market to grow at a CAGR of 3.45% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global drug-eluting stent market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drug-eluting stent products.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Drug-Eluting Stent Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Biosensors International Group
  • Boston Scientific
  • Medtronic
  • Terumo Corporation

Other Prominent Vendors

  • Biotronik
  • Cook Medical
  • Envision Scientific
  • Lepu Medical
  • Meril Life Sciences
  • MicroPort Medical
  • Opto Circuits
  • Shandong JW Medical Systems
  • STENTYS

Market driver

  • High prevalence of atherosclerosis diseases
  • For a full, detailed list, view our report

Market challenge

  • Decline in price of drug-eluting stent
  • For a full, detailed list, view our report

Market trend

  • Increasing partnership and collaboration activities
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Drug-eluting stents: An overview

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Drugs employed in drug-eluting stents

PART 08: Geographical segmentation

  • Drug-eluting stent market in Americas
  • Drug-eluting stent market in EMEA
  • Drug-eluting stent market in APAC

PART 09: Key leading countries

  • US
  • China
  • Germany
  • Japan

PART 10: Market drivers

  • High prevalence of atherosclerosis diseases
  • Favorable reimbursement scenario
  • Reduced risk of contracting restenosis
  • Technological advancements

PART 11: Impact of drivers

PART 12: Market challenges

  • Decline in price of drug-eluting stents
  • Availability of alternative procedures
  • Preference for drugs over stents
  • Risk of late-stage thrombosis

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Increasing partnership and collaboration activities
  • Growing popularity of hybrid procedures
  • Growing focus on emerging countries

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Key vendor analysis
  • Abbott Laboratories
  • Biosensors International
  • Boston Scientific
  • Medtronic
  • Terumo
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Treatment options: Percutaneous coronary intervention
  • Exhibit 03: Cross section of a stent
  • Exhibit 04: Agents used in drug-eluting stents
  • Exhibit 05: History of drug-eluting stent
  • Exhibit 06: Global drug-eluting stent market 2015-2020 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Classification of drugs used in drug-eluting stents
  • Exhibit 09: Segmentation of global drug-eluting stent market by geography 2015
  • Exhibit 10: Segmentation of global drug-eluting stent market by geography 2020
  • Exhibit 11: Segmentation of global drug-eluting stent market by geography 2015-2020
  • Exhibit 12: Drug-eluting stent market in Americas 2015-2020 ($ billions)
  • Exhibit 13: Drug-eluting stent market in EMEA 2015-2020 ($ billions)
  • Exhibit 14: Drug-eluting stent market in APAC 2015-2020 ($ billions)
  • Exhibit 15: Key leading countries
  • Exhibit 16: Market share of key leading countries in global drug-eluting stent market 2015
  • Exhibit 17: List of major biodegradable-coated drug-eluting stent products 2015
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Estimated healthcare spending in BRIC countries in 2015 ($ billions)
  • Exhibit 21: Abbott Laboratories: Key takeaways
  • Exhibit 22: Biosensors International: Business segmentation by revenue 2015
  • Exhibit 23: Biosensors International: Key takeaways
  • Exhibit 24: Boston Scientific: Business segmentation by revenue 2014
  • Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014
  • Exhibit 26: Boston Scientific: Key takeaways
  • Exhibit 27: Medtronic: Key takeaways
  • Exhibit 28: Terumo: Key takeaways
Back to Top